Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating VYN201 Gel in non-segmental vitiligo has been terminated; the sponsor Vyne Therapeutics Inc. reports the study status as TERMINATED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• VYN201 Gel

Snippet

Sponsor: Vyne Therapeutics Inc. | Conditions: Non-segmental Vitiligo | Phase 2 | Status: TERMINATED